Are you Dr. Cannon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Broadway
Ste 600
Seattle, WA 98122Phone+1 206-386-6171Fax+1 206-860-6634
Summary
- Dr. Christopher Cannon, MD is a board certified orthopedic surgeon in Seattle, Washington. He is currently licensed to practice medicine in Washington, Texas, and California. He is affiliated with Swedish Cherry Hill Campus, Seattle VA Medical Center, and MultiCare Tacoma General Hospital.
Education & Training
Madigan Army Medical CenterResidency, Orthopaedic Surgery, 1995 - 1999- Madigan Army Medical CenterInternship, Transitional Year, 1992 - 1993
University of Washington School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1999 - Present
WA State Medical License 2001 - 2025
MA State Medical License 1989 - 2017
TX State Medical License 2004 - 2010- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Start of enrollment: 2011 Aug 01
- Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- 6 citationsPopulation health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program.Jorge Plutzky, Mark D. Benson, Kira Chaney, Tiffany V. Bui, Michael Kraft
American Heart Journal. 2022-01-01 - 25 citationsLDL-C calculated by Friedewald, Martin-Hopkins, or NIH Equation 2 versus beta-quantification: pooled alirocumab trials.Henry N. Ginsberg, Robert S. Rosenson, G. Kees Hovingh, Alexia Letierce, Rita Samuel
Journal of Lipid Research. 2021-11-10 - 25 citationsBaseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-ITKazuma Oyama, Robert P. Giugliano, Michael A. Blazing, Jeong-Gun Park, Andrew M. Tershakovec
Journal of the American College of Cardiology. 2021-10-12
Press Mentions
U.S. Announces More Funding for HIV/AIDS Fight in Latin AmericaMay 22nd, 2022- ‘Promising’ HIV Vaccine Study Conducted at George Washington UniversityFebruary 3rd, 2022
The FDA Relaxed Its Gay and Bi Blood Donor Rule. It’s Still ArchaicApril 3rd, 2020- Join now to see all
Professional Memberships
- Member
